Director at Lykan Bioscience
Sal Guccione is Executive Chairman of The Emmes Company, LLC, a clinical stage contract research organization advancing pharmaceutical and public health research. He is also an Executive Advisor to New Mountain Capital, LLC and a Director of Aceto Corporation, a New Mountain-backed manufacturer and supplier of products for life sciences and other markets. Mr. Guccione brings more than 30 years of leadership experience, including CEO, CFO and strategic planning/M&A in the pharmaceutical, biotechnology and specialty chemical ingredients industries. He was President and Chief Executive Officer of Aceto Corporation until 2017. Prior to that, he was CEO of WIL Research Laboratories, a contract research organization for the pharmaceutical industry. Mr. Guccione was also Executive Vice President, Strategy, Chief Financial Officer and Vice President, Corporate Development of Cambrex Corporation, a leading active pharmaceutical ingredients company and CDMO. Prior to that, he was Vice President, General Manager of ISP Personal Care Ingredients, a global developer, manufacturer and marketer of specialty chemical ingredients for the personal care industry. Mr. Guccione holds a Bachelor of Science degree in chemical engineering from Lehigh University and an MBA in Finance from New York University’s Stern School of Business.